SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-038129
Filing Date
2024-02-16
Accepted
2024-02-16 09:08:34
Documents
18
Period of Report
2024-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d793007d8k.htm   iXBRL 8-K 51289
2 EX-2.1 d793007dex21.htm EX-2.1 671157
3 EX-99.1 d793007dex991.htm EX-99.1 14426
8 GRAPHIC g793007g0216075340254.jpg GRAPHIC 6062
  Complete submission text file 0001193125-24-038129.txt   1086918

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240216.xsd EX-101.SCH 3868
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240216_def.xml EX-101.DEF 14109
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240216_lab.xml EX-101.LAB 23493
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240216_pre.xml EX-101.PRE 15142
20 EXTRACTED XBRL INSTANCE DOCUMENT d793007d8k_htm.xml XML 7095
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 24645917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)